Physician

Paresha S. Shah, MD

According to 2025 Medicare claims, Paresha Shah, MD (NPI: 1134168776) practices allergy/immunology in the Wilmington, DE-MD-NJ market, with the plurality of this provider's patient population coming from Salem, NJ. This provider's primary affiliated billing organization is ALLERGY & ASTHMA CARE CENTER, P.A. (NPI: 1891845624; TIN: 223776439) and primary practice location at 08012-3215.

Shah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 133 traditional Medicare patients, billed 4,286 HCPCS/CPT codes, and received $68,827 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 671 prescription claims across 146 beneficiaries totaling $259,975 in drug costs, led by Dupixent Syringe (Dupilumab). DME data shows 141 claims. Open Payments data shows 47 records totaling $763. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $49,450 to $259,975. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $380 to $2,582.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	77	2,142	$30,435
2016	119	4,326	$56,532
2017	127	6,003	$74,692
2018	128	5,456	$69,740
2019	137	5,577	$78,879
2020	127	4,774	$60,449
2021	111	4,088	$65,090
2022	132	4,391	$72,436
2023	123	3,575	$63,392
2024	133	4,286	$68,827

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	51	309	$49,450
2016	83	514	$79,787
2017	93	554	$124,103
2018	99	561	$152,487
2019	116	561	$171,631
2020	109	645	$185,789
2021	110	514	$143,985
2022	115	557	$203,356
2023	114	545	$258,974
2024	146	671	$259,975

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	35	$238
2017	N/R	53	$19,295
2018	N/R	23	$22,691
2019	N/R	25	$25,519
2020	N/R	35	$41,009
2021	N/R	13	$24,243
2022	N/R	12	$20,864
2023	N/R	116	$117,074
2024	N/R	141	$184,617

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	84	129	$100
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	62	89	$71
94010	Test to measure expiratory airflow and volume	50	77	$21
95165	Professional service for preparation and provision of 1 or more antigens	66	1,962	$11
95117	Professional service for multiple injections of allergen	66	742	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Syringe	Dupilumab	13	420	$55,072
Dupixent Pen	Dupilumab	12	336	$47,008
Xolair	Omalizumab	18	504	$41,505
Breo Ellipta	Fluticasone/Vilanterol	24	1,500	$18,665
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	660	$14,400

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1555	Injection, immune globulin (cuvitru), 100 mg	N	N/R	24	$104,668
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	N	N/R	23	$50,530
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	N	N/R	12	$23,071
Q2052	Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)	N	N/R	12	$3,956
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	35	$2,109

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	47	$763	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Paresha S. Shah, MD?

Tedicare shows public-source Medicare data for Paresha S. Shah, MD (NPI 1134168776), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Paresha S. Shah, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Paresha S. Shah, MD?

Paresha S. Shah, MD is linked to ALLERGY & ASTHMA CARE CENTER, P.A. (billing NPI 1891845624) in the available physician profile data.

Does Paresha S. Shah, MD have Open Payments data?

Paresha S. Shah, MD has 47 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.